ColgatePalmolive (CL)
(Delayed Data from NYSE)
$105.81 USD
+0.02 (0.02%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $105.82 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$105.81 USD
+0.02 (0.02%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $105.82 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Zacks News
Colgate-Palmolive (CL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What to Know About Altria (MO) as It Queues for Q3 Earnings?
by Zacks Equity Research
Altria's (MO) third-quarter results are likely to reflect gains from pricing and strength in oral tobacco products amid soft cigarette volumes.
Can Keurig Dr Pepper (KDP) Beat on Q3 Earnings Amid Inflation?
by Zacks Equity Research
Keurig Dr Pepper's (KDP) Q3 results are expected to reflect gains from continued brand strength, significant pricing actions, a solid performance in its cold beverages and strong market share gains.
Brand Strength & Pricing to Aid Boston Beer's (SAM) Q3 Earnings
by Zacks Equity Research
Boston Beer's (SAM) Q3 results are expected to reflect the momentum in the Twisted Tea brand, innovation, its intensified attention to pricing and product portfolio expansion efforts.
Can Archer Daniels (ADM) Retain Its Earnings Beat Trend in Q3?
by Zacks Equity Research
A solid product portfolio, improved crush margins and resilient food demand are likely to aid Archer Daniels' (ADM) Q3 results amid inflation challenges and a soft Nutrition segment performance.
Can Coca-Cola (KO) Q3 Earnings Beat Countering Inflation Woes?
by Zacks Equity Research
Coca-Cola's (KO) Q3 results are likely to reflect the benefits of strength across markets, and gains from innovations and accelerating digital investments, offset by inflationary pressures and higher SG&A.
Simply Good Foods (SMPL) Q4 Earnings Coming Up: What to Expect
by Zacks Equity Research
Simply Good Foods' (SMPL) fourth-quarter fiscal 2023 results are likely to reflect gains from brand-building initiatives and cost-controlling efforts.
Want Better Returns? Don?t Ignore These 2 Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Procter & Gamble (PG) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 7.02% and 1.03%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Will Smoke-Free Products Fuel Philip Morris' (PM) Q3 Earnings?
by Zacks Equity Research
Philip Morris (PM) benefits from strength in the smoke-free product unit due to consumers' growing inclination toward health and wellness.
What Awaits Philip Morris (PM) as It Queues for Q3 Earnings?
by Zacks Equity Research
Philip Morris' (PM) third-quarter results are likely to reflect gains from pricing as well as strength in smoke-free products amid soft cigarette volumes.
Will Colgate-Palmolive (CL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Demand & Pricing Trends Aid PepsiCo's (PEP) Q3 Earnings?
by Zacks Equity Research
PepsiCo's (PEP) Q3 results are expected to have gained from strong demand, improved pricing, strength in its beverage and food businesses, and gains from cost- and revenue-management initiatives.
What Awaits Conagra Brands (CAG) as It Queues for Q1 Earnings?
by Zacks Equity Research
Conagra Brands' (CAG) first-quarter results are likely to reflect gains from the frozen and snacks categories. Solid pricing efforts are likely to aid amid cost inflation.
P&G (PG) Gains From Solid Product Portfolio, Pricing Actions
by Zacks Equity Research
Procter & Gamble (PG) stays afloat in a tough environment, thanks to its product portfolio, pricing actions, and productivity and cost-saving plans.
Consumer Confidence Plummets on Recession Fears: 5 Stocks to Buy
by Ritujay Ghosh
Consumer confidence is declining on recession fears. Defensive stocks like ALLETE (ALE), Consolidated Water (CWCO), American Water Works Company (AWK), Kimberly-Clark (KMB) and Colgate-Palmolive (CL) are safe bets.
Will Colgate's (CL) Innovation Efforts Boost Its Stock?
by Zacks Equity Research
Colgate (CL) suffers from rising raw material costs and inflation, as well as the impacts of pricing actions. Its innovation and expansion efforts place it well for growth in the long term.
The Zacks Analyst Blog Highlights Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva
by Zacks Equity Research
Visa, Chubb, HCA Healthcare, Colgate-Palmolive and Veeva are included in this Analyst Blog.
Top Stock Reports for Visa, Chubb & HCA Healthcare
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Chubb Limited (CB) and HCA Healthcare, Inc. (HCA).
Can Its Growth Efforts Aid Colgate (CL) Amid Cost Woes?
by Zacks Equity Research
Despite rising raw material costs and adverse currency, Colgate's (CL) robust innovation, pricing efforts and expansion plans are likely to drive growth in the long term.
The Zacks Analyst Blog Highlights Visa, Novo Nordisk, Medtronic, Shopify and Colgate-Palmolive
by Zacks Equity Research
Visa, Novo Nordisk, Medtronic, Shopify and Colgate-Palmolive are included in this Analyst Blog.
Top Stock Reports for Visa, Novo Nordisk & Medtronic
by Sheraz Mian
Today's Research Daily features new research reports on 12 major stocks, including Visa Inc. (V), Novo Nordisk A/S (NVO) and Medtronic plc (MDT).
Zacks Industry Outlook Highlights Unilever, Church & Dwight, Procter & Gamble and Colgate-Palmolive
by Zacks Equity Research
Unilever, Church & Dwight, Procter & Gamble and Colgate-Palmolive have been highlighted in this Industry Outlook article.
4 Soaps & Cleaning Materials Stocks to Gain as Industry Catches On
by Avisekh Bhattacharjee
The soap and cleaning materials industry benefits from revived demand trends, pricing actions, innovation, digital transformation and brand building. Players like UL, CHD, PG and CL look well-poised.
Colgate (CL) Q2 Earnings & Sales Surpass Estimates, View Up
by Zacks Equity Research
Colgate-Palmolive's (CL) second-quarter 2023 organic sales advance 8%, with improvements in all divisions and categories.